Introduction
During the past decade, nanobiodevice technologies, which involve a piece of contrivance, equipment, machine, or component created by the overlapping of multidisciplinary activities associated with nanotechnology and biotechnology, has progressively focused on the establishment of the four main fields of biomedical applications of nanotechnology, including disease diagnosis, in vivo bioimaging, regenerative medicine, and nano-therapy. Since nanobiodevices have tremendous advantages, [1] [2] [3] [4] [5] [6] [7] they are applicable to single-cell analysis, [8] [9] [10] single biomolecular analysis 11, 12 and the fast analysis of biomolecules developed by an appropriate small space with a short diffusion distance for cells and biomolecules, which have extremely small diffusion constants. 13 Nanomaterials, such as quantum dots, which have quantum confined effects, are essential to develop highly bright and long-life fluorescence materials, which will be indispensable for molecular imaging 14, 15 and in vivo imaging. [16] [17] [18] The research efforts in my laboratory have been focused on the development of novel nanobiodevices for biomedical applications. [1] [2] [3] [4] [5] [6] [7] In this review article, we mainly overview our research activities, including nanobiodevices for single-cell analysis, [20] [21] [22] [23] [24] [25] single biomolecule analysis, 19, [26] [27] [28] [29] 41, 46, 50, [54] [55] [56] [57] [58] biomarker detections, 23, [30] [31] [32] [33] 39, [47] [48] [49] cancer theranostics, and iPS cell in vivo imaging. [20] [21] [22] [23] [24] [25] [34] [35] [36] [37] [38] 40, [42] [43] [44] [45] [51] [52] [53] 
Microfabricated Chamber Array Chips for Detection of Circulating Tumor Cells (CTC)
Since a small number of tumor cells circulate inside blood vessels at the early stage of cancer metastasis, the detection of circulating tumor cells (CTC) is extremely important for the diagnosis of cancer and metastatic cancer. A microchamber array was fabricated on a plastic chip by a micro-molding technique so as to detect CTC as shown in Fig. 1 . Around 20000 microchambers (100 μm wide and 50 μm deep) were prepared on a chip. 21 After fabricating a chip, the surface of a chip was treated by plasma to make a hydrophobic surface. Blood was introduced onto the chip surface and we washed the chip surface by a buffer solution. These procedures allow us to make a monolayer of blood cells at the bottom of microchambers and flush out of any other blood cells from the surface of the chip as shown in Fig. 1A . The average number of the blood cells inside each microchamber is 90 ± 2. We can handle 1.8 million blood cells on a single chip. The detection of a small number of cancer cells inside a microchamber array by using a fluorescent-tagged antibody, such as anti-EpCAM antibody, and a microarray scanner was successfully demonstrated as shown in Fig. 1B .
It was confirmed the microfabridated chamber array chips enabled us to detect a single cancer cell among 1.8 million of blood cells. The technique is now being applied to clinical research in collaboration with Nagoya University hospital. We succeeded to detect a small amount of CTC from the blood of a lung cancer patient.
The detection sensitivity of the microfabricated chamber array chips for the CTC of lung cancer is much higher than that of the commercially available CTC detection system.
Nanobiodevices for Single Biomolecule Analysis
Two different types of nanofabrication technologies were established: 1) the so-called top-down nanotechnology, which is combined electron-beam lithography and plasma dry etching and 2) so-called bottom-up nanotechnology, which involves vapor-liquid-solid nanowire growth technique, to make nanopillar 2, 5, 6, 41, 46 and nanowire 56 structures with a high aspect ratio on quartz glass chips as shown in Fig. 2 . These high aspect ratio nanostructures are highly desirable for nanobiodevices, since the sizes of biomolecules and cells range from nm to μm. Nanopillar arrays, which are 100 -500 nm in diameter and 500 -5000 nm tall, as well as a nanowire array, which is 10 -100 nm in diameter and 500 -5000 nm tall, were designed and fabricated inside a microchannel several μm wide and 500 -5000 nm deep. These nanopillar array and nanowire array chips give us ultrafast separation of DNA as shown in Fig. 2B . Controlling the spacing between nanopillars and nanowires is essential to gain a higher resolving power in the separation of DNA. Single-molecule imaging of DNA (Fig. 2C) inside a nanopillar array and a nanowire array confirmed that a DNA molecule is continuously changing its conformation due to collisions with nanopillars and nanowires. 57 The probability of collisions of larger DNA molecules with nanostructures is higher than that of smaller DNA molecules, which results in achieving the separation of DNA molecules based on the difference in the migration speed of DNA molecules. This information given by single DNA molecule imaging enables us to optimize the nanostructure for fast analysis of DNA. Optimized nanostructures allow us to separate DNA, RNA, and microRNA in several seconds, as shown in Fig. 2B . We investigated how to change the arrangement of nanostructures, and found how to obtain ultrafast separation of DNA and microRNA within 1 s. These nanopillar and nanowire devices are being applied to clinical research for the gene diagnosis of cancer and other diseases.
Immunopillar Devices for Blood Biomarker Detection
Nanobiodevices are applicable to the diagnosis of diseases, including cancer, infectious diseases, and non-communicable diseases. We developed an immunopillar device, as shown in Fig. 3 .
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Immunopillar structures are fabricated with photo-polymerizing polymer inside microchannels made on a plastic chip and contain tremendous amounts of antibody-immobilized microparticles inside immunopillar structures, containing a nano-sized photo-polymeraized polymer network. Since the surface-to-volume ratio of immunopillar devices is much higher than that of conventional immunoassay techniques as well as a newly developed micro-immunoassay technique, an immunopillar device realized the fast and low invasive "from blood to analysis" type biomarker detection of cancer with a fM-pM detection sensitivity within 2 -5 min as shown in Fig. 3B . The immunopillar devices were applied to clinical research in collaboration with Nagoya University hospital, and successfully detected blood biomarkers for cancer, infectious diseases, and non-communicable diseases. These applications are extremely useful for developing low invasive and ultra-fast diagnosis of diseases by using small devices for point-of care technology.
Quantum Dots for iPS Cell-based Regenerative Medicine and Gene Delivery Nanodevices for Cancer Theranostics
Semiconductor nanocrystals, quantum dots (QDs), are an excellent example of nanomaterials that show their potential ability for biomedical applications of nanotechnologies, due to the tremendous physicochemical properties of QDs, such as bright photoluminescence and high photostability. These are attributed to their small size, shape, and chemical composition, as shown in Fig. 4 . These unique properties of QDs (Fig. 4A ) coupled with gene delivery nanobiodevices (Fig. 4C) have been initiating evolutional changes in cancer diagnosis and cancer therapy (Fig. 4) . Additionally, we developed a method to immobilize numerous biomolecules and functional molecules on QDs. These QD conjugated materials are being applied to a wide variety of biomedical applications, including cancer cell detection, cancer therapy (Fig. 4D) , 35 and in vivo imaging of iPS cells (Fig. 4B) . 36 These technologies provide us novel technologies, such as "theranostic" devices, which means the fusion of therapy and diagnosis, and iPS cell based regenerative medicine.
Conclusions
In conclusion, nanobiodevices, which have tremendous advantages, are powerful technologies for developing novel medical devices, including cancer diagnosis, cancer therapy, and iPS cell-based regenerative medicine. Nanobiodevices are essential to develop novel technology, such as theranostic devices and nano-robots for the integration of diagnosis and therapy for future personalized medicine.
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